Skip to main content

Medtronic Value Stock - Dividend - Research Selection

Medtronic

ISIN: IE00BTN1Y115 , WKN: A14M2J

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions.

 

The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software.

 

The company was founded in 1949 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Meet the 3%-Yielding Dividend Stock That Could Soar in 2026

2025-10-02
The growth of surgical robots is huge, and this company is looking to get in on the action while it also works to boost its profit margin.

This Medical Device Giant Could Be Your Best Inflation Hedge

2025-10-02
The stock can bring stability amid volatile economic conditions.

Abbott Gains Diabetes Tech Expansion Opportunity Following Earnings Beat and Insider Sale

2025-10-01
Abbott Laboratories (NYSE:ABT) is one of the 12 Set-It-and-Forget-It Stocks to Buy Now. Amid a positive second quarter and a top executive sale, the company gains an expansion opportunity from Medtronic. Abbott Laboratories (NYSE:ABT) reported a 6.9% increase in sales for the second quarter of 2025. The earnings report, announced on July 17, 2025, also […]

ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?

2025-10-01
Intuitive Surgical's SP platform secures new colorectal clearances, with 88% growth in procedures and rising global adoption momentum.

United States Continuous Glucose Monitoring (CGM) Market Forecast 2025-2033: Focus on California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, Washington, New Jersey

2025-10-01
The United States Continuous Glucose Monitoring (CGM) Market is projected to surge from US$ 2.05 billion in 2024 to US$ 4.23 billion by 2033, growing at a CAGR of 8.36% from 2025-2033. Key growth drivers include the rising prevalence of diabetes, technological advancements, enhanced insurance coverage, and increased awareness. Major players like Dexcom, Abbott, and Medtronic lead the market with user-friendly, accurate devices. The integration of CGMs is pivotal for proactive diabetes management

Medtronic Joins U.N. Call to Action Against High Blood Pressure

2025-09-30
United Nations recommends “utmost urgency” in dealing with the disease NORTHAMPTON, MA / ACCESS Newswire / September 30, 2025 / The United Nations (U.N.) called on member nations to commit "with the utmost urgency" to an ambitious goal ...

Medtronic (MDT) and its Role in a Recession-Proof Portfolio

2025-09-29
Medtronic plc (NYSE:MDT) is included among the 10 Best Recession Proof Dividend Stocks to Buy. In a recession, economic activity slows, unemployment rises, and consumer spending drops. However, defensive sectors like healthcare often hold up better since medical products and services are essential. Companies such as Medtronic plc (NYSE:MDT) benefit from this resilience. Medtronic plc […]

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

2025-09-29
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes

2025-09-29
Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal amount of 4.200% senior notes due 2045 (collectively, the "Notes"). All of Medtronic, Inc.'s obligations under the Notes are fully and unconditionally guaranteed by the Company and Medtronic Global Holdings S.C.A. ("Medtronic Luxco")

A Fresh Look at Medtronic (MDT) Valuation After FDA Green Light for Altaviva Neuromodulation Device

2025-09-28
Medtronic (MDT) just grabbed headlines with FDA approval for its Altaviva device, a minimally invasive implantable treatment for urge urinary incontinence. What sets Altaviva apart? The tiny device delivers therapy automatically near the ankle, comes with a 15-year battery life, MRI compatibility, and is ready to work before a patient even heads home from their procedure. For investors, this moment signals more than just a new product. It serves as a reminder of Medtronic’s longstanding...